---
title: 'Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia
  in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis'
date: '2023-10-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37894296/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231028180756&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: This retrospective analysis investigated the influence of integrative
  therapies in addition to palliative chemotherapy in patients with advanced pancreatic
  cancer, treated at a single institution specialized in integrative oncology between
  January 2015 and December 2019. In total, 206 consecutive patients were included
  in the study, whereof 142 patients (68.9%) received palliative chemotherapy (gemcitabine/nab-paclitaxel
  33.8%; FOLFIRINOX 35.9%; gemcitabine 30.3%) while the remainder ...
disable_comments: true
---
This retrospective analysis investigated the influence of integrative therapies in addition to palliative chemotherapy in patients with advanced pancreatic cancer, treated at a single institution specialized in integrative oncology between January 2015 and December 2019. In total, 206 consecutive patients were included in the study, whereof 142 patients (68.9%) received palliative chemotherapy (gemcitabine/nab-paclitaxel 33.8%; FOLFIRINOX 35.9%; gemcitabine 30.3%) while the remainder ...